Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

INTRA-CELLULAR THERAPIES, INC.

(ITCI)
  Report
Real-time Estimate Cboe BZX  -  09:37 2022-12-06 am EST
54.19 USD   -0.12%
12/05Insider Sell: Intra-Cellular Therapies
MT
11/10Intra-Cellular Therapies to Participate at Two Upcoming Investor Conferences
AQ
11/04RBC Lifts Price Target on Intra-Cellular Therapies to $69 From $67, Maintains Outperform Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about INTRA-CELLULAR THERAPIES, INC.
12/05Insider Sell: Intra-Cellular Therapies
MT
11/10Intra-Cellular Therapies to Participate at Two Upcoming Investor Conferences
AQ
11/04RBC Lifts Price Target on Intra-Cellular Therapies to $69 From $67, Maintains Outperfor..
MT
11/03Intra-Cellular Therapies Reports Narrower Q3 Loss, Higher Revenue; Shares Jump
MT
11/03Transcript : Intra-Cellular Therapies, Inc., Q3 2022 Earnings Call, Nov 03, 2..
CI
11/03Intra-cellular : Q3 Earnings Snapshot
AQ
11/03INTRA-CELLULAR THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
11/03Intra-Cellular Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine ..
CI
11/03Intra-cellular Therapies, Inc. : Results of Operations and Financial Condition, Other Even..
AQ
11/03Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Posts Q3 Revenue $71.9M
MT
11/03Intra-Cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corp..
AQ
10/27Intra-Cellular Therapies to Host Third Quarter 2022 Financial Results Conference Call a..
AQ
10/06RBC Cuts Price Target on Intra-Cellular Therapies to $67 From $70, Maintains Outperform..
MT
09/26Insider Sell: Intra-Cellular Therapies
MT
08/22Analyst recommendations: Snowflake, Vipshop, UIta Beauty, VF, Ad..
MS
08/22Goldman Sachs Cuts Intra-Cellular Therapies to Neutral From Buy, Price Target to $49 Fr..
MT
08/15Insider Sell: Intra-Cellular Therapies
MT
08/11Mizuho Securities Adjusts Intra-Cellular Therapies' Price Target to $72 From $75, Keeps..
MT
08/10Needham Adjusts Intra-Cellular Therapies' Price Target to $67 from $65, Keeps Buy Ratin..
MT
08/10Goldman Sachs Lowers Intra-Cellular Therapies' Price Target to $64 From $71, Maintains ..
MT
08/09Intra Cellular Therapies : REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND PROVIDES CORP..
PU
08/09Transcript : Intra-Cellular Therapies, Inc., Q2 2022 Earnings Call, Aug 09, 2..
CI
08/09Intra-Cellular Therapies Q2 Net Loss Widens, Revenue Climbs
MT
08/09INTRA-CELLULAR THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
08/09Intra-cellular : Q2 Earnings Snapshot
AQ
08/09Intra-cellular Therapies, Inc. : Results of Operations and Financial Condition, Other Even..
AQ
08/09Intra-Cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Cor..
AQ
08/09Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Reports Q2 Revenue $55.6M
MT
08/09Intra-Cellular Therapies, Inc. Reports Earnings Results for the Second Quarter and Six ..
CI
08/02Intra-Cellular Therapies to Host Second Quarter 2022 Financial Results Conference Call ..
AQ
07/07Mizuho Securities Initiates Intra-Cellular Therapies at Buy with $75 Price Target
MT
07/07RBC Lifts Price Target on Intra-Cellular Therapies to $71 From $70, Maintains Outperfor..
MT
07/06Mizuho Initiates Intra-Cellular Therapies With Buy Rating, $75 Price Target, Cites 'Add..
MT
06/14UBS Initiates Coverage on Intra-Cellular Therapies With Buy Rating, $75 Price Target
MT
06/13Intra-cellular Therapies, Inc. : Submission of Matters to a Vote of Security Holders (form..
AQ
06/13Intra-Cellular Therapies Highlights Lumateperone Bipolar Depression Data Presentations ..
AQ
05/10Sector Update: Health Care Stocks Carried Higher by Surging Biotechs
MT
05/10Sector Update: Health Care Stocks Still Edging Higher This Afternoon
MT
05/10Intra-Cellular Therapies Q1 Loss Expands; Revenue Rises; Shares Rise Tuesday Afternoon
MT
05/10Intra-Cellular Therapies Q1 Loss Expands; Revenue Rises
MT
05/10Transcript : Intra-Cellular Therapies, Inc., Q1 2022 Earnings Call, May 10, 2..
CI
05/10INTRA-CELLULAR THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
05/10Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Posts Q1 Revenue $35M
MT
05/10Intra-cellular : Q1 Earnings Snapshot
AQ
05/10Intra-cellular Therapies, Inc. : Results of Operations and Financial Condition, Other Even..
AQ
05/10Intra-Cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corp..
AQ
05/10Intra-Cellular Therapies, Inc. Reports Earnings Results for the First Quarter Ended Mar..
CI
05/03Intra-Cellular Therapies to Host First Quarter 2022 Financial Results Conference Call a..
AQ
04/26Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA (lu..
AQ
04/25Intra-Cellular Therapies Says FDA Approves Two New Dosage Strengths for Treatment of Sc..
MT
04/25Intra Cellular Therapies : Announces FDA Approval of New Dosage Strengths for CAPLYTA« (lu..
PU
04/25Intra-cellular Therapies, Inc. : Other Events, Financial Statements and Exhibits (form 8-K..
AQ
04/25Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA« (l..
AQ
04/25Intra-Cellular Therapies, Inc. Announces FDA Approval of New Dosage Strengths for CAPLY..
CI
04/22Piper Sandler Starts Intra-Cellular Therapies at Neutral With $59 Price Target
MT
04/21SVB Leerink Adjusts Intra-Cellular Therapies Price Target to $70 From $65, Maintains Ou..
MT
04/21Intra Cellular Therapies : Announces Appointment of E. Rene Salas to Board of Directors - ..
PU
04/21Intra-cellular Therapies, Inc. : Change in Directors or Principal Officers, Financial Stat..
AQ
04/21Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors
AQ
04/21Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors a..
CI
04/11Insider Sell: Intra-Cellular Therapies
MT
04/06RBC Capital Adjusts Intra-Cellular Therapies' Price Target to $70 From $65, Maintains O..
MT
04/05Intra-Cellular Therapies to Present at the 21st Annual Needham Virtual Healthcare Confe..
AQ
03/21Insider Sell: Intra-Cellular Therapies
MT
03/06Certain Restricted Stock Unit of Intra-Cellular Therapies, Inc. are subject to a Lock-U..
CI
03/06Certain Common Stock of Intra-Cellular Therapies, Inc. are subject to a Lock-Up Agreeme..
CI
03/06Certain Option of Intra-Cellular Therapies, Inc. are subject to a Lock-Up Agreement End..
CI
03/02SVB Leerink Adjusts Intra-Cellular Therapies' Price Target to $65 from $50, Keeps Outpe..
MT
03/01Transcript : Intra-Cellular Therapies, Inc., Q4 2021 Earnings Call, Mar 01, 2..
CI
03/01Intra-Cellular Therapies Widens Q4 Net Loss as Revenue Doubles
MT
03/01Intra Cellular Therapies : REPORTS FOURTH QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS AND..
PU
03/01Intra-cellular Therapies, Inc. : Results of Operations and Financial Condition, Other Even..
AQ
03/01Intra-Cellular Therapies, Inc. Reports Earnings Results for the Fourth Quarter Ended De..
CI
03/01Intra-cellular : Q4 Earnings Snapshot
AQ
03/01INTRA-CELLULAR THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
1  2  3  4  5  6  7  8  9Next
Upcoming event on INTRA-CELLULAR THERAPIES, INC.